NPI: 1487640207 · WASHINGTON, DC 20037 · Family Nurse Practitioner · NPI assigned 09/27/2005
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (CFO, SENIOR VP) |
| NPI Enumeration Date | 09/27/2005 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 297,778 | $17.05M |
| 2019 | 338,843 | $20.65M |
| 2020 | 295,118 | $16.57M |
| 2021 | 305,160 | $18.79M |
| 2022 | 254,635 | $23.15M |
| 2023 | 197,802 | $22.12M |
| 2024 | 146,190 | $17.94M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 78,361 | 31,430 | $17.43M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 46,090 | 40,880 | $10.05M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 45,458 | 41,180 | $9.96M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 37,835 | 33,003 | $8.50M |
| 96361 | Intravenous infusion, hydration; each additional hour | 15,158 | 13,018 | $8.03M |
| 70450 | Computed tomography, head or brain; without contrast material | 12,350 | 11,288 | $3.34M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3,814 | 3,494 | $2.81M |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 34,837 | 15,011 | $2.81M |
| 19083 | 1,584 | 1,482 | $2.62M | |
| 97535 | Self-care/home management training, each 15 minutes | 10,880 | 7,414 | $2.51M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 3,329 | 3,079 | $2.25M |
| 77386 | 4,740 | 422 | $2.24M | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9,816 | 9,107 | $2.20M |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 25,995 | 22,631 | $2.16M |
| 59025 | Fetal non-stress test | 6,302 | 4,809 | $1.97M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 20,147 | 10,406 | $1.92M |
| 97161 | 9,582 | 8,983 | $1.85M | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 2,195 | 2,053 | $1.81M |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 1,251 | 1,136 | $1.73M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 5,379 | 2,629 | $1.71M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 15,394 | 13,856 | $1.64M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7,200 | 6,353 | $1.59M |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 13,429 | 6,999 | $1.59M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 14,905 | 11,252 | $1.52M |
| 71275 | Computed tomographic angiography, chest, with contrast material | 4,517 | 4,161 | $1.37M |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1,636 | 1,505 | $1.30M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 9,156 | 6,641 | $1.28M |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 5,979 | 5,491 | $1.28M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 11,961 | 10,435 | $1.19M |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 3,358 | 2,798 | $1.17M |
| 76642 | 5,578 | 5,390 | $1.09M | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 6,954 | 6,702 | $1.09M |
| 97597 | 5,790 | 3,610 | $1.08M | |
| G0378 | Hospital observation service, per hour | 7,295 | 6,211 | $1.03M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7,364 | 6,549 | $980K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2,084 | 1,965 | $935K |
| 97016 | 7,893 | 3,224 | $906K | |
| 97162 | 4,360 | 4,092 | $897K | |
| 76830 | Ultrasound, transvaginal | 7,702 | 7,393 | $806K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 10,294 | 10,070 | $790K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,849 | 2,672 | $780K |
| 97116 | 6,763 | 3,660 | $736K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,004 | 1,818 | $701K |
| 64483 | 565 | 545 | $690K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,798 | 3,950 | $684K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 2,467 | 2,325 | $674K |
| 72197 | 1,401 | 1,352 | $673K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 2,559 | 2,374 | $632K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3,188 | 2,514 | $629K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 4,054 | 3,765 | $628K |
| 97165 | 2,758 | 2,577 | $582K | |
| 70496 | 1,595 | 1,490 | $546K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 4,329 | 4,086 | $543K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 484 | 447 | $518K |
| 71046 | Radiologic examination, chest; 2 views | 23,801 | 21,887 | $490K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 13,573 | 11,204 | $480K |
| 64493 | 649 | 548 | $478K | |
| 77412 | 562 | 78 | $453K | |
| 93971 | 3,391 | 3,146 | $445K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 2,052 | 1,939 | $435K |
| 29581 | 2,043 | 714 | $416K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1,801 | 740 | $408K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1,301 | 1,247 | $381K |
| 76641 | 1,481 | 1,418 | $366K | |
| 72141 | 1,560 | 1,462 | $362K | |
| 71250 | 3,437 | 3,161 | $359K | |
| 73630 | 7,746 | 7,235 | $356K | |
| 76536 | 2,159 | 2,070 | $349K | |
| 97166 | 1,830 | 1,679 | $348K | |
| 77066 | Tomosynthesis, mammo | 5,507 | 5,302 | $335K |
| 74183 | 801 | 732 | $330K | |
| 76775 | 2,319 | 2,220 | $312K | |
| 97018 | 2,571 | 1,091 | $311K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | 2,976 | 1,384 | $295K |
| 77336 | 2,729 | 1,238 | $289K | |
| 77065 | Tomosynthesis, mammo | 4,745 | 4,335 | $264K |
| 80048 | Basic metabolic panel (calcium, ionized) | 52,938 | 40,240 | $252K |
| 93970 | 1,343 | 1,254 | $233K | |
| 93975 | 1,643 | 1,528 | $217K | |
| 76801 | 2,683 | 2,411 | $214K | |
| 77014 | 6,228 | 621 | $192K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 932 | 683 | $189K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 48,352 | 39,791 | $187K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 3,581 | 3,113 | $185K |
| 70486 | 3,020 | 2,782 | $166K | |
| 80053 | Comprehensive metabolic panel | 32,549 | 26,851 | $154K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 799 | 780 | $149K |
| 20610 | 478 | 407 | $146K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 541 | 499 | $145K |
| 19081 | 83 | 77 | $144K | |
| 99215 | Prolong outpt/office vis | 416 | 365 | $144K |
| 77280 | 522 | 430 | $142K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 10,159 | 9,943 | $130K |
| 10060 | 498 | 441 | $127K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8,024 | 6,477 | $126K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6,050 | 5,629 | $121K |
| 74174 | 838 | 764 | $121K | |
| 73221 | 481 | 460 | $120K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 587 | 519 | $119K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,710 | 2,395 | $117K |
| 73130 | 4,327 | 3,978 | $109K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 4,745 | 4,391 | $108K |
| 90715 | 3,548 | 3,359 | $108K | |
| 73030 | 4,272 | 3,941 | $104K | |
| G0465 | Autologous platelet rich plasma (prp) or other blood-derived product for diabetic chronic wounds/ulcers, using an fda-cleared device for this indication, (includes as applicable administration, dressings, phlebotomy, centrifugation or mixing, and all other preparatory procedures, per treatment) | 60 | 25 | $103K |
| 73562 | 2,836 | 2,661 | $101K | |
| 70491 | 469 | 436 | $98K | |
| 72100 | 2,444 | 2,300 | $90K | |
| 83880 | 9,445 | 8,470 | $79K | |
| 73564 | 3,339 | 3,150 | $75K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 6,198 | 6,042 | $74K |
| 76870 | 676 | 643 | $73K | |
| 73610 | 3,694 | 3,359 | $72K | |
| 58571 | 13 | 12 | $70K | |
| 97163 | 437 | 404 | $67K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 79,904 | 61,325 | $66K |
| 72040 | 1,283 | 1,208 | $62K | |
| 10160 | 216 | 202 | $61K | |
| 74178 | 213 | 198 | $57K | |
| 77290 | 172 | 147 | $56K | |
| 71045 | Radiologic examination, chest; single view | 15,227 | 13,167 | $55K |
| 71271 | 299 | 297 | $54K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 11,763 | 9,213 | $54K |
| 15271 | 28 | 12 | $52K | |
| 73110 | 2,466 | 2,244 | $51K | |
| 77334 | 340 | 261 | $51K | |
| 97598 | 710 | 496 | $49K | |
| 73502 | 2,216 | 2,088 | $48K | |
| 36561 | 13 | 13 | $47K | |
| 84484 | 27,812 | 20,826 | $46K | |
| 77080 | 464 | 456 | $43K | |
| 36415 | Collection of venous blood by venipuncture | 99,726 | 69,753 | $40K |
| 72110 | 700 | 668 | $39K | |
| 80076 | 15,548 | 13,295 | $38K | |
| 70498 | 1,354 | 1,276 | $37K | |
| 12001 | 128 | 126 | $35K | |
| 86923 | 1,202 | 835 | $35K | |
| 87040 | 3,763 | 2,454 | $34K | |
| 97032 | 119 | 64 | $34K | |
| 43235 | 59 | 51 | $33K | |
| 97164 | 111 | 109 | $33K | |
| 86850 | 11,055 | 9,670 | $32K | |
| 78306 | 92 | 87 | $31K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 14,950 | 12,834 | $30K |
| 84702 | 7,565 | 6,632 | $30K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 77 | 55 | $27K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,595 | 1,414 | $27K |
| 70544 | 61 | 55 | $25K | |
| 64454 | 46 | 40 | $24K | |
| 88307 | 770 | 548 | $24K | |
| 72131 | 368 | 346 | $23K | |
| 20553 | 85 | 76 | $23K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 138 | 116 | $23K |
| 12011 | 85 | 80 | $22K | |
| 85379 | 3,515 | 3,175 | $21K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,572 | 1,485 | $21K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 84 | 83 | $21K |
| 88341 | 1,172 | 939 | $20K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 4,177 | 3,688 | $19K |
| 86900 | 12,018 | 10,475 | $19K | |
| 72070 | 555 | 528 | $18K | |
| 82962 | 28,949 | 17,782 | $18K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,308 | 1,185 | $18K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 677 | 604 | $17K |
| 81001 | 42,386 | 36,300 | $17K | |
| 88342 | 3,655 | 3,186 | $17K | |
| 73080 | 1,359 | 1,261 | $17K | |
| 85027 | 8,652 | 6,587 | $16K | |
| 72120 | 204 | 192 | $16K | |
| 83735 | 25,964 | 16,960 | $16K | |
| 83605 | 10,057 | 7,917 | $16K | |
| 92523 | 116 | 106 | $16K | |
| 20560 | 128 | 68 | $15K | |
| 80197 | 4,498 | 2,404 | $15K | |
| 97022 | 189 | 93 | $15K | |
| 86901 | 12,037 | 10,491 | $14K | |
| 77300 | 194 | 172 | $13K | |
| 73522 | 390 | 373 | $12K | |
| 73590 | 1,488 | 1,344 | $12K | |
| 97542 | 47 | 38 | $12K | |
| 77001 | 75 | 75 | $12K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5,907 | 5,493 | $11K |
| 77338 | 14 | 13 | $11K | |
| 74018 | 357 | 302 | $11K | |
| 72050 | 153 | 147 | $10K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 8,587 | 7,413 | $10K |
| 80051 | 2,670 | 2,412 | $10K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 25,369 | 22,571 | $10K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 16,801 | 15,657 | $10K |
| 12002 | 43 | 39 | $10K | |
| 81514 | 37 | 36 | $9K | |
| 84443 | Thyroid stimulating hormone (TSH) | 6,867 | 6,163 | $9K |
| 97139 | 267 | 160 | $9K | |
| 82803 | 7,263 | 5,881 | $8K | |
| 77301 | 13 | 12 | $8K | |
| 85610 | 12,213 | 10,217 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 15,783 | 13,261 | $7K |
| 88304 | 875 | 745 | $7K | |
| 85730 | 8,626 | 7,415 | $6K | |
| 75574 | 13 | 13 | $6K | |
| 96367 | 437 | 370 | $6K | |
| 73560 | 234 | 211 | $6K | |
| 99201 | 25 | 25 | $6K | |
| 81025 | 18,049 | 16,657 | $6K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 105 | 85 | $6K |
| 72170 | 582 | 541 | $6K | |
| C1769 | Guide wire | 2,190 | 1,919 | $6K |
| 83690 | 14,208 | 12,761 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3,675 | 3,408 | $6K |
| 84100 | 8,160 | 4,716 | $6K | |
| 87486 | 372 | 310 | $6K | |
| 88312 | 549 | 424 | $5K | |
| 62323 | 25 | 24 | $5K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 114 | 63 | $5K |
| 73700 | 33 | 30 | $5K | |
| 87507 | 142 | 127 | $4K | |
| 80061 | Lipid panel | 2,091 | 1,918 | $4K |
| 96376 | 5,113 | 4,134 | $4K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 13 | 13 | $4K |
| 87210 | 3,746 | 3,520 | $4K | |
| Q0247 | Injection, sotrovimab, 500 mg | 20 | 19 | $4K |
| 87077 | 3,174 | 2,364 | $4K | |
| 97760 | 34 | 28 | $4K | |
| 86803 | 401 | 359 | $4K | |
| 73140 | 348 | 324 | $4K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 2,660 | 2,411 | $4K |
| 87799 | 659 | 470 | $4K | |
| 73090 | 708 | 647 | $3K | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 20 | 19 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,574 | 2,375 | $3K |
| 87070 | 3,564 | 3,167 | $3K | |
| 62322 | 12 | 12 | $3K | |
| 87581 | 372 | 310 | $3K | |
| 82565 | 10,855 | 10,084 | $3K | |
| 82075 | 1,800 | 1,422 | $3K | |
| 77470 | 14 | 12 | $3K | |
| 87497 | 540 | 448 | $3K | |
| 73552 | 315 | 290 | $3K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 12,595 | 10,947 | $3K |
| 88112 | 131 | 114 | $3K | |
| C1776 | Joint device (implantable) | 41 | 41 | $3K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 401 | 327 | $2K |
| 88142 | 117 | 112 | $2K | |
| 70547 | 30 | 26 | $2K | |
| 86140 | 3,184 | 2,811 | $2K | |
| 85014 | 4,255 | 3,738 | $2K | |
| 20561 | 20 | 12 | $2K | |
| 74420 | 28 | 25 | $2K | |
| J2704 | Injection, propofol, 10 mg | 17,741 | 15,461 | $2K |
| 80050 | General health panel | 679 | 628 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 372 | 339 | $2K |
| 86592 | 1,254 | 1,130 | $2K | |
| 76942 | 30 | 26 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,169 | 1,434 | $2K |
| C1729 | Catheter, drainage | 1,814 | 1,606 | $1K |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 1,635 | 1,453 | $1K |
| 72052 | 26 | 24 | $1K | |
| 87205 | 2,512 | 2,103 | $1K | |
| 82570 | 2,094 | 1,577 | $1K | |
| 87186 | 3,380 | 2,852 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 12 | 12 | $1K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 79 | 72 | $1K |
| 84439 | 793 | 731 | $1K | |
| 73060 | 198 | 182 | $1K | |
| 82374 | 2,157 | 1,948 | $1K | |
| 74230 | 16 | 12 | $1K | |
| 90686 | 95 | 83 | $1K | |
| 85018 | 4,219 | 3,706 | $1K | |
| 82728 | 597 | 491 | $1K | |
| 82550 | 2,646 | 2,221 | $1K | |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | 14 | 12 | $1K |
| 85651 | 2,863 | 2,585 | $1K | |
| 36430 | 117 | 86 | $981.39 | |
| 87640 | 28 | 28 | $896.56 | |
| 86703 | 493 | 454 | $894.05 | |
| G0008 | Administration of influenza virus vaccine | 94 | 82 | $883.49 |
| 87430 | 798 | 770 | $800.33 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 18,527 | 16,205 | $800.32 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 5,375 | 4,271 | $734.79 |
| 84481 | 376 | 351 | $712.21 | |
| 83970 | 111 | 97 | $656.41 | |
| 92610 | 30 | 24 | $648.73 | |
| 83615 | 1,349 | 1,053 | $594.24 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 8,305 | 7,194 | $592.72 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 862 | 803 | $563.24 |
| 82607 | 246 | 224 | $553.65 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 5,503 | 5,132 | $551.30 |
| 87641 | 28 | 28 | $500.78 | |
| 87116 | 27 | 24 | $491.97 | |
| 73620 | 38 | 26 | $486.89 | |
| 72128 | 16 | 13 | $479.71 | |
| 84156 | 1,462 | 1,051 | $442.25 | |
| 84466 | 452 | 402 | $422.80 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 836 | 745 | $384.05 |
| 83540 | 518 | 457 | $377.92 | |
| J3473 | Injection, hyaluronidase, recombinant, 1 usp unit | 14 | 14 | $348.22 |
| 73660 | 18 | 17 | $323.10 | |
| 87653 | 31 | 29 | $299.99 | |
| 87340 | 492 | 441 | $297.61 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 13,233 | 11,605 | $280.49 |
| C1889 | Implantable/insertable device, not otherwise classified | 14 | 14 | $263.83 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 18,812 | 15,639 | $239.62 |
| 0353U | 818 | 781 | $231.94 | |
| 84132 | 998 | 849 | $228.83 | |
| 90714 | 13 | 12 | $225.26 | |
| 85045 | 442 | 325 | $213.15 | |
| 89051 | 119 | 104 | $200.23 | |
| J1630 | Injection, haloperidol, up to 5 mg | 2,251 | 1,904 | $197.47 |
| 87503 | 24 | 22 | $185.30 | |
| 74019 | 13 | 13 | $174.15 | |
| 86706 | 260 | 232 | $169.87 | |
| 85576 | 31 | 26 | $164.31 | |
| 64495 | 182 | 148 | $163.18 | |
| 82248 | 304 | 275 | $152.54 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 11,157 | 9,833 | $146.01 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 5,987 | 3,289 | $143.50 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 4,731 | 3,716 | $142.32 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 6,934 | 5,651 | $136.72 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 86 | 82 | $135.75 |
| 73600 | 13 | 12 | $131.02 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 4,103 | 3,572 | $117.53 |
| 87899 | 255 | 235 | $108.87 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 88 | 77 | $96.58 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 229 | 223 | $83.62 |
| 86704 | 70 | 64 | $81.36 | |
| 84295 | 816 | 697 | $78.19 | |
| J2060 | Injection, lorazepam, 2 mg | 2,821 | 2,310 | $77.40 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 691 | 598 | $74.16 |
| 88173 | 15 | 14 | $71.60 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 346 | 224 | $66.99 |
| 86308 | 66 | 64 | $64.54 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,158 | 812 | $57.86 |
| 85384 | 146 | 115 | $57.56 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 163 | 152 | $52.09 |
| J0690 | Injection, cefazolin sodium, 500 mg | 7,382 | 5,857 | $51.28 |
| 82436 | 50 | 41 | $49.47 | |
| A9270 | Non-covered item or service | 34,493 | 10,348 | $45.35 |
| J1170 | Injection, hydromorphone, up to 4 mg | 10,211 | 6,735 | $39.03 |
| 84300 | 136 | 113 | $32.15 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,671 | 3,053 | $30.03 |
| C1780 | Lens, intraocular (new technology) | 1,159 | 1,037 | $27.18 |
| 0250 | 4,368 | 1,496 | $24.64 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 823 | 724 | $22.23 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 489 | 466 | $17.60 |
| J1644 | Injection, heparin sodium, per 1000 units | 5,697 | 3,308 | $15.59 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 1,785 | 1,501 | $13.25 |
| 87341 | 27 | 25 | $12.72 | |
| 84133 | 50 | 41 | $12.37 | |
| 87075 | 106 | 92 | $12.10 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 3,247 | 2,523 | $9.31 |
| 87102 | 63 | 54 | $5.02 | |
| J3490 | Unclassified drugs | 89 | 38 | $4.27 |
| 87206 | 26 | 24 | $2.51 | |
| 84460 | 47 | 42 | $2.13 | |
| 84550 | 41 | 39 | $1.96 | |
| J1940 | Injection, furosemide, up to 20 mg | 1,115 | 714 | $0.87 |
| C9113 | Injection, pantoprazole sodium, per vial | 187 | 105 | $0.24 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 71 | 69 | $0.01 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 19 | 17 | $0.01 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 365 | 327 | $0.01 |
| 0272 | 100 | 100 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 770 | 682 | $0.00 |
| G8989 | Self care functional limitation, discharge status, at discharge from therapy or to end reporting | 31 | 29 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 363 | 328 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 778 | 724 | $0.00 |
| 99152 | 248 | 215 | $0.00 | |
| 77002 | 44 | 37 | $0.00 | |
| J1953 | Injection, levetiracetam, 10 mg | 244 | 194 | $0.00 |
| 84450 | 32 | 29 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 169 | 164 | $0.00 |
| C1765 | Adhesion barrier | 25 | 24 | $0.00 |
| J0694 | Injection, cefoxitin sodium, 1 gm | 267 | 213 | $0.00 |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 27 | 27 | $0.00 |
| 76376 | 35 | 35 | $0.00 | |
| 85347 | 91 | 81 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 905 | 847 | $0.00 |
| 88302 | 13 | 12 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 805 | 715 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 47 | 39 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 98 | 71 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 26 | 26 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 16 | 12 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 17 | 15 | $0.00 |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | 12 | 12 | $0.00 |
| 76937 | 13 | 12 | $0.00 | |
| G0390 | Trauma response team associated with hospital critical care service | 13 | 13 | $0.00 |
| 76000 | 12 | 12 | $0.00 | |
| 76818 | 13 | 13 | $0.00 | |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 116 | 113 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 185 | 171 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 2,352 | 1,310 | $0.00 |
| 0710 | 283 | 281 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 857 | 780 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 389 | 356 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 375 | 322 | $0.00 |
| 64494 | 364 | 309 | $0.00 | |
| 99153 | Mod sedat endo service >5yrs | 165 | 137 | $0.00 |
| 82330 | 15 | 14 | $0.00 | |
| J3480 | Injection, potassium chloride, per 2 meq | 135 | 84 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 391 | 337 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 46 | 42 | $0.00 |
| C1763 | Connective tissue, non-human (includes synthetic) | 237 | 219 | $0.00 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 27 | 26 | $0.00 |
| J8501 | Aprepitant, oral, 5 mg | 12 | 12 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 50 | 36 | $0.00 |
| 77417 | 29 | 14 | $0.00 | |
| C1781 | Mesh (implantable) | 14 | 13 | $0.00 |
| 64484 | 12 | 12 | $0.00 | |
| 36416 | 18 | 12 | $0.00 | |
| 0270 | 19 | 18 | $0.00 | |
| 85390 | 19 | 14 | $0.00 | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 15 | 13 | $0.00 |